Kaiser Permanente Health Research Institute
Seattle, Washington, 98101, United States
NCT Number: NCT05777772
STOP-FALLS-D is an educational intervention to inform and activate patients, their care partner(s), and their primary care providers to work together to reduce use of central nervous system (CNS) active medications and prevent adverse outcomes (falls and injuries) associated with their use.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Seattle, Washington, 98101, United States
The study design is a pragmatic, one-arm pilot trial to test the feasibility and acceptability of implementing a deprescribing intervention with older people with dementia and their care partners in primary care. The intervention consists of patient-facing educational brochures on CNS-active medications and decision support for the primary care provider. Ethnic/minority groups will be over-sampled to ensure a diverse study sample.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Older Adult Sample
Inclusion criteria
Exclusion criteria
Care Partner Sample
Inclusion criteria
This is one-arm, health-system embedded pragmatic pilot trial
Time frame: Through study completion, up to 6 months
Number of older adult participants with dementia with a fall-related healthcare visit
Time frame: Through study completion, up to 6 months
Number of older adult participants with dementia with an emergency department visit or hospitalization for any reason
Time frame: Through study completion, up to 6 months
Number of older adult participants with dementia admitted to a skilled nursing facility
University of Washington
Other
Acronym: STOP-FALLS-D
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07306065
Alzheimer Disease, Alzheimers Disease
Orlando, Florida, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial Details